- Home
- AXSM vs HHH Comparison
AXSM vs HHH Comparison
Compare AXSM & HHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- HHH
- Stock Information
- Founded
- AXSM 2012
- HHH 2010
- Country
- AXSM United States
- HHH United States
- Employees
- AXSM N/A
- HHH N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- HHH Real Estate Investment Trusts
- Sector
- AXSM Health Care
- HHH Real Estate
- Exchange
- AXSM Nasdaq
- HHH Nasdaq
- Market Cap
- AXSM 5.1B
- HHH 3.3B
- IPO Year
- AXSM 2015
- HHH N/A
- Fundamental
- Price
- AXSM $110.12
- HHH $69.26
- Analyst Decision
- AXSM Strong Buy
- HHH Buy
- Analyst Count
- AXSM 17
- HHH 2
- Target Price
- AXSM $171.65
- HHH $80.50
- AVG Volume (30 Days)
- AXSM 672.7K
- HHH 492.2K
- Earning Date
- AXSM 08-04-2025
- HHH 08-06-2025
- Dividend Yield
- AXSM N/A
- HHH N/A
- EPS Growth
- AXSM N/A
- HHH N/A
- EPS
- AXSM N/A
- HHH 5.22
- Revenue
- AXSM $432,157,000.00
- HHH $1,793,533,000.00
- Revenue This Year
- AXSM $62.57
- HHH N/A
- Revenue Next Year
- AXSM $59.96
- HHH $24.62
- P/E Ratio
- AXSM N/A
- HHH $13.23
- Revenue Growth
- AXSM 72.16
- HHH 106.40
- 52 Week Low
- AXSM $72.21
- HHH $59.83
- 52 Week High
- AXSM $139.13
- HHH $87.77
- Technical
- Relative Strength Index (RSI)
- AXSM 56.52
- HHH 56.11
- Support Level
- AXSM $108.48
- HHH $68.15
- Resistance Level
- AXSM $114.66
- HHH $71.59
- Average True Range (ATR)
- AXSM 3.47
- HHH 1.37
- MACD
- AXSM 0.87
- HHH 0.27
- Stochastic Oscillator
- AXSM 64.95
- HHH 78.96
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About HHH Howard Hughes Holdings Inc.
Howard Hughes Holdings Inc owns, manages, and develops commercial, residential, and mixed-use real estate throughout the USA. Its portfolio is strategically positioned to meet and accelerate development based on market demand, resulting in one of the strongest real estate platforms in the country. It operates through four business segments: Operating Assets, MPCs, Strategic Developments and Seaport.